This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window
American Economic Review: Vol. 100 No. 1 (March 2010)
AER Volume. 100, Issue 1 | 
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter
AER Forthcoming Articles
Full-text Article
Download Data Set (3.28 MB)
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter
Explore:
AER Forthcoming Articles
The Effect of Medicare Part D on Pharmaceutical Prices and Utilization
Article Citation
Duggan, Mark, and
Fiona Scott Morton. 2010. "The Effect of Medicare Part D on Pharmaceutical Prices and Utilization."
American Economic Review,
100(1): 590-607.
DOI: 10.1257/aer.100.1.590
DOI: 10.1257/aer.100.1.590
Abstract
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical prices, the government contracted with private insurers to provide drug coverage. Theory suggests that additional insured consumers will raise the optimal price of a branded drug, while the insurer's ability to move demand to substitute treatments may lower prices. We estimate the program's effect on the price and utilization of pharmaceutical treatments. We find that Part D enrollees paid substantially lower prices than while uninsured, and increased their utilization of prescription drugs. We find relative price declines only for drugs with significant therapeutic competition. (L18, L11, L65)
Article Full-Text Access
Full-text Article
Additional Materials
Download Data Set (3.28 MB)
Authors
Duggan, Mark (U MD)
Scott Morton, Fiona (Yale U)
Scott Morton, Fiona (Yale U)
JEL Classifications
I18: Health: Government Policy; Regulation; Public Health
L11: Production, Pricing, and Market Structure; Size Distribution of Firms
L65: Chemicals; Rubber; Drugs; Biotechnology
L11: Production, Pricing, and Market Structure; Size Distribution of Firms
L65: Chemicals; Rubber; Drugs; Biotechnology
